Clinical Trials Logo
  1. Home
  2. Other
  3. NCT02065167

Evaluation of Mesenchymal Stem Cells to Treat Avascular Necrosis of the Hip — ORTHO-2  

Avascular Necrosis of the Femoral Head Clinical Trial

Official title:
Evaluation of Safety and Feasibility of Bone Marrow Derived Autologous MSCs to Enhance Bone Healing in Patients With Avascular Necrosis of the Femoral Head

Clinical Trial Summary

The purpose is to assess the safety and feasibility of cellular therapy derived from bone marrow, to help bone healing in patients with avascular necrosis of the hip.

Clinical Trial Description

To assess the safety and feasibility of an in situ single injection of a high dose of autologous bone marrow-derived, in vitro expanded Mesenchymal stem cells, and its contribution to the resolution of the early stages of avascular osteonecrosis of the femoral head. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02065167
Study type Interventional
Source Universidad Autonoma de Madrid
Contact
Status Completed
Phase Phase 2
Start date February 2014
Completion date December 2017
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04731077 - Avenir Complete Post-Market Clinical Follow-Up Study N/A
Recruiting NCT05227924 - Safety and Performance Assessment of the SYMBOL Range of Medical Devices in Patients Underlying Total Hip Arthroplasty
Completed NCT01643655 - Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Avascular Necrosis of the Femoral Head N/A
Active, not recruiting NCT02662881 - Biologically Assisted Core Decompression of the Femoral Head Using the PerFuse Instrument and BioCUE
Active, not recruiting NCT05186168 - Corin MiniHip and Trinity Cup Clinical Surveillance Study
Recruiting NCT02552069 - Tritanium® Study in Japan
Recruiting NCT05460715 - The Medacta Quadra-P Anteverted Study
Recruiting NCT02748408 - The Medacta International SMS Post-Marketing Surveillance Study
Not yet recruiting NCT06123481 - Autologous Bone Marrow Aspirate Treatment for Early-Stage Osteonecrosis N/A
Recruiting NCT02783274 - Actis Total Hip System 2 Year Follow-up N/A
Withdrawn NCT03753282 - Outcome After Avascular Necrosis of the Femoral Head in Young Patients
Completed NCT03639532 - Ceramic-on-Ceramic Versus Ceramic-on-HXLPE THA Phase 4
Recruiting NCT05982054 - Bone Marrow Cells With Core Decompression for AVN Treatment N/A
Active, not recruiting NCT04997005 - The Medacta International AMIStem-P Post-Marketing Surveillance Study